502 related articles for article (PubMed ID: 31362865)
41. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
West MA; Baker WC; Rahman S; Munro A; Jack S; Grocott MP; Underwood TJ; Levett DZ;
J Surg Oncol; 2021 Dec; 124(8):1306-1316. PubMed ID: 34463378
[TBL] [Abstract][Full Text] [Related]
42. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
43. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
[TBL] [Abstract][Full Text] [Related]
44. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
Tan BH; Brammer K; Randhawa N; Welch NT; Parsons SL; James EJ; Catton JA
Eur J Surg Oncol; 2015 Mar; 41(3):333-8. PubMed ID: 25498359
[TBL] [Abstract][Full Text] [Related]
45. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
46. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
Prado CM; Cushen SJ; Orsso CE; Ryan AM
Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
[TBL] [Abstract][Full Text] [Related]
47. Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.
Guinan EM; Doyle SL; Bennett AE; O'Neill L; Gannon J; Elliott JA; O'Sullivan J; Reynolds JV; Hussey J
Support Care Cancer; 2018 May; 26(5):1569-1576. PubMed ID: 29197960
[TBL] [Abstract][Full Text] [Related]
48. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer.
Sandini M; Bernasconi DP; Fior D; Molinelli M; Ippolito D; Nespoli L; Caccialanza R; Gianotti L
Nutrition; 2016; 32(11-12):1231-7. PubMed ID: 27261062
[TBL] [Abstract][Full Text] [Related]
49. Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.
Miyake M; Owari T; Iwamoto T; Morizawa Y; Hori S; Marugami N; Shimada K; Iida K; Ohnishi K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Yoneda T; Tanaka N; Fujimoto K
Support Care Cancer; 2018 Apr; 26(4):1077-1086. PubMed ID: 29022158
[TBL] [Abstract][Full Text] [Related]
50. Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy.
Ueno A; Yamaguchi K; Sudo M; Imai S
Support Care Cancer; 2020 Sep; 28(9):4249-4254. PubMed ID: 31900607
[TBL] [Abstract][Full Text] [Related]
51. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
52. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
53. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
[TBL] [Abstract][Full Text] [Related]
54. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of sarcopenia in older patients with colorectal cancer.
Broughman JR; Williams GR; Deal AM; Yu H; Nyrop KA; Alston SM; Gordon BB; Sanoff HK; Muss HB
J Geriatr Oncol; 2015 Nov; 6(6):442-5. PubMed ID: 26365898
[TBL] [Abstract][Full Text] [Related]
56. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment.
Sheean PM; Peterson SJ; Gomez Perez S; Troy KL; Patel A; Sclamberg JS; Ajanaku FC; Braunschweig CA
JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):873-9. PubMed ID: 23980135
[TBL] [Abstract][Full Text] [Related]
58. Sarcopenia and low muscle radiodensity associate with impaired FEV
Mishra A; Bigam KD; Extermann M; Faramand R; Thomas K; Pidala JA; Baracos VE
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1570-1579. PubMed ID: 32729255
[TBL] [Abstract][Full Text] [Related]
59. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
[TBL] [Abstract][Full Text] [Related]
60. Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
Jang MK; Park S; Park C; Doorenbos AZ; Go J; Kim S
Breast; 2022 Dec; 66():1-7. PubMed ID: 36063619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
